The primary outcome was CVD defined as any first event of the following: acute myocardial infarction, unstable angina, either ischemic or hemorrhagic cerebral stroke, congestive heart failure, symptomatic arrhythmia, aggravated valvular heart, pericardial disease, abdominal aortic aneurysm, and severe peripheral arterial disease that required hospitalization, intervention, or therapy during the follow-up. The secondary outcome was a composite of CVD and all-cause death. For the present study, data were collected until drop-out, death, or March 31, 2018, whichever came first.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.